Pandey R, Natarajan P, Reddy U, Du W, Sirbu C, Sissoko M
PLoS One. 2025; 20(1):e0318185.
PMID: 39874307
PMC: 11774404.
DOI: 10.1371/journal.pone.0318185.
Matsumoto K, Akieda Y, Haraoka Y, Hirono N, Sasaki H, Ishitani T
Nat Commun. 2024; 15(1):10662.
PMID: 39690179
PMC: 11652645.
DOI: 10.1038/s41467-024-55108-x.
Sarott R, Gourisankar S, Karim B, Nettles S, Yang H, Dwyer B
Science. 2024; 386(6717):eadl5361.
PMID: 39361741
PMC: 11629774.
DOI: 10.1126/science.adl5361.
Lo C, Alavi P, Bassey-Archibong B, Jahroudi N, Pasdar M
PLoS One. 2024; 19(10):e0306705.
PMID: 39361615
PMC: 11449273.
DOI: 10.1371/journal.pone.0306705.
Sharma V, Chaudhary A, Bawari S, Gupta S, Mishra R, Khan S
Front Pharmacol. 2024; 15:1414790.
PMID: 39246660
PMC: 11377287.
DOI: 10.3389/fphar.2024.1414790.
Mouse models to investigate in situ cell fate decisions induced by p53.
Lieschke E, Thomas A, Kueh A, Atkin-Smith G, Baldoni P, La Marca J
EMBO J. 2024; 43(19):4406-4436.
PMID: 39160273
PMC: 11445477.
DOI: 10.1038/s44318-024-00189-z.
Determinants of p53 DNA binding, gene regulation, and cell fate decisions.
Fischer M, Sammons M
Cell Death Differ. 2024; 31(7):836-843.
PMID: 38951700
PMC: 11239874.
DOI: 10.1038/s41418-024-01326-1.
Rotenone Induces a Neuropathological Phenotype in Cholinergic-like Neurons Resembling Parkinson's Disease Dementia (PDD).
Giraldo-Berrio D, Mendivil-Perez M, Velez-Pardo C, Jimenez-Del-Rio M
Neurotox Res. 2024; 42(3):28.
PMID: 38842585
PMC: 11156752.
DOI: 10.1007/s12640-024-00705-3.
The MDM2-p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem Cells.
Nakagawa-Saito Y, Mitobe Y, Togashi K, Suzuki S, Sugai A, Takenouchi S
Int J Mol Sci. 2024; 25(7).
PMID: 38612758
PMC: 11011437.
DOI: 10.3390/ijms25073948.
FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5.
Takeda K, Ohta S, Nagao M, Kobayashi E, Tago K, Funakoshi-Tago M
Int J Mol Sci. 2024; 25(7).
PMID: 38612503
PMC: 11011477.
DOI: 10.3390/ijms25073693.
Kinase signalling adaptation supports dysfunctional mitochondria in disease.
Skalka G, Tsakovska M, Murphy D
Front Mol Biosci. 2024; 11:1354682.
PMID: 38434478
PMC: 10906720.
DOI: 10.3389/fmolb.2024.1354682.
Sex Differences in Colon Cancer: Genomic and Nongenomic Signalling of Oestrogen.
Harvey B, Harvey H
Genes (Basel). 2023; 14(12).
PMID: 38137047
PMC: 10742859.
DOI: 10.3390/genes14122225.
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses.
La Marca J, Aubrey B, Yang B, Chang C, Wang Z, Kueh A
Cell Death Differ. 2023; 31(2):150-158.
PMID: 38097622
PMC: 10850147.
DOI: 10.1038/s41418-023-01249-3.
miR-222 inhibits pathological cardiac hypertrophy and heart failure.
Liu X, Li H, Hastings M, Xiao C, Damilano F, Platt C
Cardiovasc Res. 2023; 120(3):262-272.
PMID: 38084908
PMC: 10939454.
DOI: 10.1093/cvr/cvad184.
Mechanisms of UV-induced human lymphocyte apoptosis.
Nakvasina M, Holyavka M, Artyukhov V, Radchenko M, Lidokhova O
Biophys Rev. 2023; 15(5):1257-1267.
PMID: 37974997
PMC: 10643441.
DOI: 10.1007/s12551-023-01142-w.
Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements.
Trauernicht M, Rastogi C, Manzo S, Bussemaker H, van Steensel B
Nucleic Acids Res. 2023; 51(18):9690-9702.
PMID: 37650627
PMC: 10570033.
DOI: 10.1093/nar/gkad718.
BCL-W makes only minor contributions to MYC-driven lymphoma development.
Diepstraten S, La Marca J, Chang C, Young S, Strasser A, Kelly G
Oncogene. 2023; 42(37):2776-2781.
PMID: 37567974
PMC: 10491490.
DOI: 10.1038/s41388-023-02804-5.
Cholinergic-like neurons and cerebral spheroids bearing the PSEN1 p.Ile416Thr variant mirror Alzheimer's disease neuropathology.
Gomez-Sequeda N, Mendivil-Perez M, Jimenez-Del-Rio M, Lopera F, Velez-Pardo C
Sci Rep. 2023; 13(1):12833.
PMID: 37553376
PMC: 10409854.
DOI: 10.1038/s41598-023-39630-4.
Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis.
Ding D, Blee A, Zhang J, Pan Y, Becker N, Maher 3rd L
Nat Commun. 2023; 14(1):4671.
PMID: 37537199
PMC: 10400651.
DOI: 10.1038/s41467-023-40352-4.
A lncRNA from the FTO locus acts as a suppressor of the mA writer complex and p53 tumor suppression signaling.
Zhang J, Wei J, Sun R, Sheng H, Yin K, Pan Y
Mol Cell. 2023; 83(15):2692-2708.e7.
PMID: 37478845
PMC: 10427207.
DOI: 10.1016/j.molcel.2023.06.024.